BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37141408)

  • 1. AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function.
    Braun T; Klepzig H; Herling M
    Oncotarget; 2023 May; 14():395-397. PubMed ID: 37141408
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
    Staber PB; Herling M; Bellido M; Jacobsen ED; Davids MS; Kadia TM; Shustov A; Tournilhac O; Bachy E; Zaja F; Porkka K; Hoermann G; Simonitsch-Klupp I; Haferlach C; Kubicek S; Mayerhoefer ME; Hopfinger G; Jaeger U; Dearden C
    Blood; 2019 Oct; 134(14):1132-1143. PubMed ID: 31292114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia.
    Braun T; Stachelscheid J; Bley N; Oberbeck S; Otte M; Müller TA; Wahnschaffe L; Glaß M; Ommer K; Franitza M; Gathof B; Altmüller J; Hallek M; Auguin D; Hüttelmaier S; Schrader A; Herling M
    Cancer Res; 2022 May; 82(9):1818-1831. PubMed ID: 35259248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
    Frater JL
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():90-98. PubMed ID: 32543075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level.
    Patil P; Hillebrecht S; Chteinberg E; López C; Toprak UH; Seufert J; Bernhart SH; Kretzmer H; Bergmann AK; Bens S; Högel J; Müller A; Jebaraj BM; Schrader A; Johansson P; Costa D; Schlesner M; Dürig J; Herling M; Campo E; Stilgenbauer S; Wiehle L; Siebert R
    Genes Chromosomes Cancer; 2022 Jul; 61(7):432-436. PubMed ID: 35218115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
    Patil P; Cieslak A; Bernhart SH; Toprak UH; Wagener R; López C; Wiehle L; Bens S; Altmüller J; Franitza M; Scholz I; Jayne S; Ahearne MJ; Scheffold A; Jebaraj BMC; Schneider C; Costa D; Braun T; Schrader A; Campo E; Dyer MJS; Nürnberg P; Dürig J; Johansson P; Böttcher S; Schlesner M; Herling M; Stilgenbauer S; Macintyre E; Siebert R
    Genes Chromosomes Cancer; 2020 Apr; 59(4):261-267. PubMed ID: 31677197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research Advances of Genetics, Diagnosis and Treatment of T-cell Prolymphocytic Leukemia--Review].
    Lai MF; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1977-1981. PubMed ID: 34893145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic Blebs in T-Cell Prolymphocytic Leukemia.
    Abbas HA; Han X
    N Engl J Med; 2019 Jun; 380(24):2360. PubMed ID: 31189039
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous presentation of T-cell prolymphocytic leukemia.
    Ventre MO; Bacelieri RE; Lazarchick J; Pollack RB; Metcalf JS
    Cutis; 2013 Feb; 91(2):87-91. PubMed ID: 23513557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell prolymphocytic leukemia presenting as ascites.
    Hermans SJF; Sandberg Y
    Blood; 2019 Jul; 134(4):411. PubMed ID: 31345928
    [No Abstract]   [Full Text] [Related]  

  • 15. The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemia.
    Erkeland SJ; Stavast CJ; Schilperoord-Vermeulen J; Dal Collo G; Van de Werken HJG; Leon LG; Van Hoven-Beijen A; Van Zuijen I; Mueller YM; Bindels EM; De Ridder D; Kappers-Klunne MC; Van Lom K; Van der Velden VHJ; Langerak AW
    Haematologica; 2022 Jan; 107(1):143-153. PubMed ID: 33596640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
    Gallipoli P; Clark A; Leach M
    Am J Hematol; 2009 Nov; 84(11):750-3. PubMed ID: 19714590
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of Novel
    Kanagal-Shamanna R; Bao H; Kearney H; Smoley S; Tang Z; Luthra R; Yang H; Zhang S; Lin P; Wu D; Medeiros LJ; Lu X
    Leuk Lymphoma; 2022 Apr; 63(4):865-875. PubMed ID: 34898335
    [No Abstract]   [Full Text] [Related]  

  • 18. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
    Fang H; Beird HC; Wang SA; Ibrahim AF; Tang Z; Tang G; You MJ; Hu S; Xu J; Li S; Yin CC; El Hussein S; Le N; Futreal PA; Bueso-Ramos C; Thakral B; Kadia TM; Thornton R; Little L; Gumbs C; Song X; Medeiros LJ; Wang W
    Leukemia; 2023 Sep; 37(9):1919-1921. PubMed ID: 37443196
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
    Kiel MJ; Velusamy T; Rolland D; Sahasrabuddhe AA; Chung F; Bailey NG; Schrader A; Li B; Li JZ; Ozel AB; Betz BL; Miranda RN; Medeiros LJ; Zhao L; Herling M; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Aug; 124(9):1460-72. PubMed ID: 24825865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T cell prolymphocytic leukaemia.
    Cross M; Dearden C
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.